1. ALLA AKTIER
  2. NYHETER
  3. PROLIGHT DIAGNOSTICS

Prolight Diagnostics

Nyheter Prolight Diagnostics Nyheter alla bolag

Prolight invites to digital investor meeting due to recent achieved milestones

In connection with the subscription period for Prolight Diagnostics AB’s (Prolight’ or the ‘Company’) rights issue of shares, which runs between June 16 and June 30, 2025, the Company invites shareholders and external investors to a digital investor meeting. The meeting will be held via Microsoft Teams on June 24, 2025, at 14:00 CEST.

During the meeting, Prolight's CEO Ulf Bladin will present the company's recent progress, including the first results from the whole blood study at St Thomas' Hospital in London, what the results enable and upcoming milestones. During the investor meeting, there will be an opportunity to ask questions directly via the chat function.

Registration
Please register by emailing corporatefinance@mangold.se as soon as possible, no later than Monday, June 23, 2025. Questions can be submitted in advance and will be answered during the Q&A session if time allows. It will also be possible to ask questions live during the meeting.

More information about the rights issue is available on Prolights website.

Indicative timetable

June 16 – June 25, 2025Trading in subscription rights (TR) on NGM
June 16 – June 30, 2025Subscription period in the Rights Issue
June 16 – July 16, 2025Expected trading in paid subscribed shares
(BTA) on NGM
July 2, 2025Estimated date for announcement of issue outcome

For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com

About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.
 
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Attachments
Prolight invites to digital investor meeting due to recent achieved milestones

Datum 2025-06-17, kl 18:40
Källa MFN
Bifogade filer
Prolight invites to digital investor meeting due to recent achieved milestones
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.